nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing the nephrology workforce shortage via a novel undergraduate pipeline program: the Kidney Disease Screening and Awareness Program (KDSAP) at 10 years
|
Jiang, Ming-Yan |
|
|
100 |
6 |
p. 1174-1178 |
artikel |
2 |
A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)
|
May, Rebecca M. |
|
|
100 |
6 |
p. 1303-1315 |
artikel |
3 |
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
|
Bertrand, Dominique |
|
|
100 |
6 |
p. 1337-1340 |
artikel |
4 |
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target
|
Eikelboom, John |
|
|
100 |
6 |
p. 1199-1207 |
artikel |
5 |
Antiresorptives in patients with chronic kidney disease with adynamic bone: Is absence of evidence of harm equal to no harm?
|
El-Husseini, Amr |
|
|
100 |
6 |
p. 1341-1342 |
artikel |
6 |
A randomized multicenter trial on a lung ultrasound–guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk
|
Zoccali, Carmine |
|
|
100 |
6 |
p. 1325-1333 |
artikel |
7 |
A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients
|
Daloul, Reem |
|
|
100 |
6 |
p. 1190-1198 |
artikel |
8 |
Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis
|
Gulati, Kavita |
|
|
100 |
6 |
p. 1316-1324 |
artikel |
9 |
Contactin-1–associated membranous nephropathy: complete immunologic and clinical remission with rituximab
|
Plaisier, Emmanuelle |
|
|
100 |
6 |
p. 1342-1344 |
artikel |
10 |
Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy
|
Le Quintrec, Moglie |
|
|
100 |
6 |
p. 1240-1249 |
artikel |
11 |
Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707–715
|
Heybeli, Cihan |
|
|
100 |
6 |
p. 1348-1349 |
artikel |
12 |
Corrigendum to Liu J, Kesiry R, Periyasamy SM, et al. Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int. 2004;66:227–241
|
|
|
|
100 |
6 |
p. 1348 |
artikel |
13 |
Corrigendum to Mann JFE, Muskiet MHA. Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists. Kidney Int. 2021;99:314–318
|
|
|
|
100 |
6 |
p. 1351-1352 |
artikel |
14 |
Corrigendum to Wu L, Liu C, Chang D-Y, et al. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int. 2021;100:107–121
|
|
|
|
100 |
6 |
p. 1349-1350 |
artikel |
15 |
Editorial Board
|
|
|
|
100 |
6 |
p. A1 |
artikel |
16 |
Erratum to Shankar AS, Du Z, Mora HT, et al. Human kidney organoids produce functional renin. Kidney Int. 2021;99:134–147
|
|
|
|
100 |
6 |
p. 1346-1347 |
artikel |
17 |
Granuloma formation after peritoneal dialysis catheter–related infection by Mycobacterium chelonae
|
Noda, Ryunosuke |
|
|
100 |
6 |
p. 1355 |
artikel |
18 |
How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not
|
van Gelder, Teun |
|
|
100 |
6 |
p. 1185-1189 |
artikel |
19 |
Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody–induced pulmonary-renal syndrome
|
Enghard, Philipp |
|
|
100 |
6 |
p. 1344-1345 |
artikel |
20 |
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
|
Stervbo, Ulrik |
|
|
100 |
6 |
p. 1335-1337 |
artikel |
21 |
In This Issue
|
|
|
|
100 |
6 |
p. 1149 |
artikel |
22 |
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease
|
Mehta, Rupal C. |
|
|
100 |
6 |
p. 1292-1302 |
artikel |
23 |
Journal Club
|
|
|
|
100 |
6 |
p. 1150-1151 |
artikel |
24 |
Kidney toxicity of phosphate: is that crystal clear yet?
|
Letavernier, Emmanuel |
|
|
100 |
6 |
p. 1155-1157 |
artikel |
25 |
Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition
|
Bai, Yuntao |
|
|
100 |
6 |
p. 1214-1226 |
artikel |
26 |
Linking transcription to energy: the path to understand kidney injury
|
Miguel, Verónica |
|
|
100 |
6 |
p. 1165-1167 |
artikel |
27 |
Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy
|
Spain, Rebecca I. |
|
|
100 |
6 |
p. 1208-1213 |
artikel |
28 |
Loss of proximal tubular transcription factor Krüppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation
|
Piret, Sian E. |
|
|
100 |
6 |
p. 1250-1267 |
artikel |
29 |
Management of fluid overload in hemodialysis patients
|
Lopez, Tony |
|
|
100 |
6 |
p. 1170-1173 |
artikel |
30 |
Massive renal angiomyolipomas in tuberous sclerosis complex
|
Chong, Grace Y. |
|
|
100 |
6 |
p. 1354 |
artikel |
31 |
Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease
|
Ponte, Belen |
|
|
100 |
6 |
p. 1282-1291 |
artikel |
32 |
New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
|
Zavala-Miranda, María Fernanda |
|
|
100 |
6 |
p. 1340-1341 |
artikel |
33 |
Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism
|
Bissinger, Rosi |
|
|
100 |
6 |
p. 1227-1239 |
artikel |
34 |
Recent advances in lineage tracing for the kidney
|
Muto, Yoshiharu |
|
|
100 |
6 |
p. 1179-1184 |
artikel |
35 |
Rescuing kidney patients from early demise: role of anti-cytokine therapies
|
Ikizler, T. Alp |
|
|
100 |
6 |
p. 1152-1154 |
artikel |
36 |
Role of proteinuria in the anemia of chronic kidney disease
|
Drüeke, Tilman B. |
|
|
100 |
6 |
p. 1160-1162 |
artikel |
37 |
Strawberry gingivitis
|
Muller, Romain |
|
|
100 |
6 |
p. 1353 |
artikel |
38 |
Subscription Information
|
|
|
|
100 |
6 |
p. A3 |
artikel |
39 |
The Case | A nonhealing skin ulcer in a patient 5 years after successful transplantation
|
Choi, Mira |
|
|
100 |
6 |
p. 1357-1358 |
artikel |
40 |
The semaphorin 4A–neuropilin 1 axis alleviates kidney ischemia reperfusion injury by promoting the stability and function of regulatory T cells
|
Xu, Junnan |
|
|
100 |
6 |
p. 1268-1281 |
artikel |
41 |
TOC - 5 pages
|
|
|
|
100 |
6 |
p. A5, A7, A9, A11, A13 |
artikel |
42 |
UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease
|
Turner, Michael |
|
|
100 |
6 |
p. 1168-1170 |
artikel |
43 |
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelatase
|
Yamada, Ryo |
|
|
100 |
6 |
p. 1158-1160 |
artikel |
44 |
Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost
|
Davidovic, Tamara |
|
|
100 |
6 |
p. 1334-1335 |
artikel |
45 |
When contactin antibodies hit the podocyte: a new neurorenal syndrome
|
Debiec, Hanna |
|
|
100 |
6 |
p. 1163-1165 |
artikel |